Clinical Trials Directory

Trials / Completed

CompletedNCT03448016

[C-11]NOP-1A and Alcohol Use Disorder

Linking Nociceptive Opioid Peptide (NOP) Receptors With Relapse in Alcoholism

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Rajesh Narendran · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to compare \[C-11\]NOP-1A binding in recently abstinent alcohol use disorders and controls

Detailed description

This will allow for understanding brain stress and antistress mechanisms that underlie abuse of alcohol in humans

Conditions

Interventions

TypeNameDescription
RADIATION[C-11]Radiolabel
DRUGNOP-1ATracer

Timeline

Start date
2016-05-27
Primary completion
2021-03-30
Completion
2021-03-30
First posted
2018-02-27
Last updated
2022-07-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03448016. Inclusion in this directory is not an endorsement.

[C-11]NOP-1A and Alcohol Use Disorder (NCT03448016) · Clinical Trials Directory